Ironwood Pharmaceuticals Inc (IRWD) — Cash Flow-to-Debt Ratio
Ironwood Pharmaceuticals Inc (IRWD) has a Cash Flow-to-Debt Ratio of 0.13x as of June 2026, meaning its operating cash flow of $58.28 Million could theoretically repay 0% of its total liabilities ($446.97 Million) in one year. See how financially flexible is Ironwood Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ironwood Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Ironwood Pharmaceuticals Inc across 19 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Ironwood Pharmaceuticals Inc.
Annual Cash Flow-to-Debt Ratio for Ironwood Pharmaceuticals Inc (2007–2025)
Year-by-year debt coverage analysis for Ironwood Pharmaceuticals Inc. Check Ironwood Pharmaceuticals Inc (IRWD) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | $127.04 Million | $658.74 Million | ▲ +21.5% |
| 2024 | 0.16x | $103.55 Million | $652.24 Million | ▼ -29.3% |
| 2023 | 0.22x | $183.43 Million | $817.37 Million | ▼ -63.3% |
| 2022 | 0.61x | $273.76 Million | $448.14 Million | ▲ +21.5% |
| 2021 | 0.50x | $261.89 Million | $521.02 Million | ▲ +47.8% |
| 2020 | 0.34x | $168.84 Million | $496.60 Million | ▲ +1472.3% |
| 2019 | 0.02x | $10.72 Million | $496.00 Million | ▲ +116.1% |
| 2018 | -0.13x | $-70.88 Million | $528.42 Million | ▲ +19.7% |
| 2017 | -0.17x | $-99.56 Million | $595.83 Million | ▼ -322.5% |
| 2016 | -0.04x | $-25.43 Million | $643.11 Million | ▲ +80.6% |
| 2015 | -0.20x | $-106.93 Million | $524.00 Million | ▲ +67.9% |
| 2014 | -0.64x | $-155.57 Million | $244.96 Million | ▲ +44.1% |
| 2013 | -1.14x | $-273.36 Million | $240.74 Million | ▼ -40.0% |
| 2012 | -0.81x | $-69.63 Million | $85.86 Million | ▼ -6.9% |
| 2011 | -0.76x | $-75.24 Million | $99.12 Million | ▼ -58.5% |
| 2010 | -0.48x | $-67.90 Million | $141.81 Million | ▼ -5418.3% |
| 2009 | -0.01x | $-4.00 Million | $460.79 Million | ▲ +88.6% |
| 2008 | -0.08x | $-28.20 Million | $371.13 Million | ▼ -253.2% |
| 2007 | -0.02x | $-6.76 Million | $314.28 Million | — |